Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs EFX✓SelectedUSD · EFXGSK vs EFX performance historyLatest closeAs of-0.13%11/20
Stock and ETF performance explorer

GSK vs EFX

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+41.1%
EFX return
-35.8%
Excess return
+76.9%
Maximum drawdown
-37.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioEFXExcessAlpha
1D-0.1%+0.4%-0.5%-0.2%
7D-5.3%-5.8%+0.5%-4.5%
30D-3.7%+0.9%-4.6%-3.8%
3M-7.3%-7.6%+0.4%-6.4%
6M-4.2%+8.2%-12.4%-5.7%
YTD+0.9%-17.6%+18.5%+2.7%
1Y+7.3%-13.3%+20.6%+8.3%
3Y+52.7%-13.3%+66.1%+53.8%
All+41.1%-35.8%+76.9%+44.0%

Cumulative growth

Daily Returns

Daily percentage return beside EFX.

Daily Out/Under-Performance

Portfolio return minus EFX return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × EFX return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded EFX wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling